Literature DB >> 28496723

Conversion of Persistent Atrial Fibrillation After Radiofrequency Ablation by Ibutilide.

Pipin Kojodjojo1.   

Abstract

Ablation of peristent AF remains challenging with questions unanswered about what the ideal next step after pulmonary venous isolation should be. Ibutilide is a highly effective class III agent for cardioversion of acute-onset atrial flutter and fibrillation, with limited clinical use due to risks of ventricular pro-arrhythmias. However, results from the on-going MAGIC-AF trial may re-invigorate its role in clinical electrophysiology as an invaluable adjunct to facilitate controlled substrate modification during ablation of persistent AF.

Entities:  

Year:  2012        PMID： 28496723      PMCID： PMC5153012          DOI： 10.4022/jafib.500

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  16 in total

Review 1.  Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.

Authors:  Madhuri Nair; Lekha K George; Santhosh K G Koshy
Journal:  J Am Board Fam Med       Date:  2011 Jan-Feb       Impact factor: 2.657

2.  Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.

Authors:  Nikolaos V Kafkas; Sotirios P Patsilinakos; George A Mertzanos; Kostas I Papageorgiou; John I Chaveles; Ourania K Dagadaki; Kostas M Kelesidis
Journal:  Int J Cardiol       Date:  2006-10-17       Impact factor: 4.164

3.  The Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation (MAGIC-AF) Study: clinical background and study design.

Authors:  Sheldon M Singh; Andre D'Avila; Young-Hoon Kim; Arash Aryana; J Michael Mangrum; Gregory F Michaud; Srinivas R Dukkipati; David J Callans; Conor D Barrett; Maximo R Beras-Jovine; Vivek Y Reddy
Journal:  J Cardiovasc Electrophysiol       Date:  2011-10-28

4.  Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function.

Authors:  Kristina Lemola; Benoit Desjardins; Michael Sneider; Ian Case; Aman Chugh; Eric Good; Jihn Han; Kamala Tamirisa; Ariane Tsemo; Scott Reich; David Tschopp; Petar Igic; Darryl Elmouchi; Frank Bogun; Frank Pelosi; Ella Kazerooni; Fred Morady; Hakan Oral
Journal:  Heart Rhythm       Date:  2005-09       Impact factor: 6.343

5.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

6.  Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint.

Authors:  Mark D O'Neill; Matthew Wright; Sébastien Knecht; Pierre Jaïs; Mélèze Hocini; Yoshihide Takahashi; Anders Jönsson; Frédéric Sacher; Seiichiro Matsuo; Kang Teng Lim; Leonardo Arantes; Nicolas Derval; Nicholas Lellouche; Isabelle Nault; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  Eur Heart J       Date:  2009-03-08       Impact factor: 29.983

Review 7.  Female preponderance in ibutilide-induced torsade de pointes.

Authors:  Ramesh M Gowda; Ijaz A Khan; Gopikrishna Punukollu; Balendu C Vasavada; Terrence J Sacchi; Sabrina L Wilbur
Journal:  Int J Cardiol       Date:  2004-06       Impact factor: 4.164

8.  Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation.

Authors:  Sébastien Knecht; Mélèze Hocini; Matthew Wright; Nicolas Lellouche; Mark D O'Neill; Seiichiro Matsuo; Isabelle Nault; Vijay S Chauhan; Kevin J Makati; Michela Bevilacqua; Kang-Teng Lim; Frederic Sacher; Antoine Deplagne; Nicolas Derval; Pierre Bordachar; Pierre Jaïs; Jacques Clémenty; Michel Haïssaguerre
Journal:  Eur Heart J       Date:  2008-07-08       Impact factor: 29.983

9.  Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation.

Authors:  Heidi Luise Estner; Gabriele Hessling; Gjin Ndrepepa; Jinjin Wu; Tilko Reents; Stefanie Fichtner; Claus Schmitt; Christian V Bary; Christof Kolb; Martin Karch; Bernhard Zrenner; Isabel Deisenhofer
Journal:  Europace       Date:  2008-08-29       Impact factor: 5.214

10.  Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation.

Authors:  Sheldon M Singh; Andre D'Avila; Steven J Kim; Christopher Houghtaling; Srinivas R Dukkipati; Vivek Y Reddy
Journal:  J Cardiovasc Electrophysiol       Date:  2009-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.